Cargando…

Suppression of local type I interferon by gut microbiota–derived butyrate impairs antitumor effects of ionizing radiation

The antitumor effects of ionizing radiation (IR) are mediated in part through activation of innate and adaptive immunity. Here we report that gut microbiota influences tumor control following IR. Vancomycin decreased the abundance of butyrate-producing gut bacteria and enhanced antitumor responses t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Kaiting, Hou, Yuzhu, Zhang, Yuan, Liang, Hua, Sharma, Anukriti, Zheng, Wenxin, Wang, Liangliang, Torres, Rolando, Tatebe, Ken, Chmura, Steven J., Pitroda, Sean P., Gilbert, Jack A., Fu, Yang-Xin, Weichselbaum, Ralph R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2021
Materias:	Brief Definitive Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844434/ https://www.ncbi.nlm.nih.gov/pubmed/33496784 http://dx.doi.org/10.1084/jem.20201915

Ejemplares similares

Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling
por: Shi, Yaoyao, et al.
Publicado: (2020)

Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade
por: Si, Wei, et al.
Publicado: (2022)

Tumor-reprogrammed resident T cells resist radiation to control tumors
por: Arina, Ainhoa, et al.
Publicado: (2019)

ACKR4 restrains antitumor immunity by regulating CCL21
por: Whyte, Carly E., et al.
Publicado: (2020)

microRNAs and oligometastasis
por: Khodarev, Nikolai N., et al.
Publicado: (2015)

Oligometastatic prostate cancer: Reality or figment of imagination?
por: Foster, Corey C., et al.
Publicado: (2018)

Treatment of Cancer with Radio-Immunotherapy: What We Currently Know and What the Future May Hold
por: Turchan, William Tyler, et al.
Publicado: (2021)

Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy
por: Turchan, William Tyler, et al.
Publicado: (2022)

Induced sensitization of tumor stroma leads to eradication of established cancer by T cells
por: Zhang, Bin, et al.
Publicado: (2007)

Tumor‐Activatable Nanoparticles Target Low‐Density Lipoprotein Receptor to Enhance Drug Delivery and Antitumor Efficacy
por: Jiang, Xiaomin, et al.
Publicado: (2022)

TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells
por: Kaiser, Frank, et al.
Publicado: (2009)

Suppression of Lymphoma and Epithelial Malignancies Effected by Interferon γ
por: Street, Shayna E.A., et al.
Publicado: (2002)

Interferon γ Is Required for Activation-induced Death of T Lymphocytes
por: Refaeli, Yosef, et al.
Publicado: (2002)

Involvement of Tweak in Interferon γ–Stimulated Monocyte Cytotoxicity
por: Nakayama, Masafumi, et al.
Publicado: (2000)

The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses
por: Pachynski, Russell K., et al.
Publicado: (2012)

Transcriptional role of p53 in interferon-mediated antiviral immunity
por: Muñoz-Fontela, César, et al.
Publicado: (2008)

Deficiencies of GM-CSF and Interferon γ Link Inflammation and Cancer
por: Enzler, Thomas, et al.
Publicado: (2003)

Inflammatory Cytokine Profiles During Exercise in Obese, Diabetic, and Healthy Children
por: Galassetti, Pietro R., et al.
Publicado: (2011)

Complementary and Alternative Medicine in Children with Type 1 Diabetes Mellitus
por: Haliloglu, Belma, et al.
Publicado: (2011)

3M Syndrome: A Report of Four Cases in Two Families
por: Güven, Ayla, et al.
Publicado: (2011)

Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies
por: Bulliard, Yannick, et al.
Publicado: (2013)

Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes
por: Auerbuch, Victoria, et al.
Publicado: (2004)

Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling
por: Lepelley, Alice, et al.
Publicado: (2020)

Ionizing Radiation and Chemotherapeutic Drugs Induce Apoptosis in Lymphocytes in the Absence of FAS or Fadd/Mort1 Signaling: Implications for Cancer Therapy
por: Newton, Kim, et al.
Publicado: (2000)

Type I interferon signaling is required for activation of the inflammasome during Francisella infection
por: Henry, Thomas, et al.
Publicado: (2007)

Autocrine Secretion of Interferon γ Negatively Regulates Homing of Immature B Cells
por: Flaishon, Liat, et al.
Publicado: (2000)

Type I Interferon Sensitizes Lymphocytes to Apoptosis and Reduces Resistance to Listeria Infection
por: Carrero, Javier A., et al.
Publicado: (2004)

Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo
por: Swiecki, Melissa, et al.
Publicado: (2011)

Type I interferon drives tumor necrosis factor–induced lethal shock
por: Huys, Liesbeth, et al.
Publicado: (2009)

Type I interferon signaling mediates Mycobacterium tuberculosis–induced macrophage death
por: Zhang, Li, et al.
Publicado: (2020)

Type I interferons drive MAIT cell functions against bacterial pneumonia
por: López-Rodríguez, Juan Carlos, et al.
Publicado: (2023)

A Study of the Interferon Antiviral Mechanism: Apoptosis Activation by the 2–5A System
por: Castelli, JoAnn C., et al.
Publicado: (1997)

Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response
por: Fang, Terry C., et al.
Publicado: (2012)

CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells
por: Chen, Zhangguo, et al.
Publicado: (2011)

Tumor-derived soluble CD155 inhibits DNAM-1–mediated antitumor activity of natural killer cells
por: Okumura, Genki, et al.
Publicado: (2020)

Interleukin 12–dependent Interferon γ Production by CD8α(+)Lymphoid Dendritic Cells
por: Ohteki, Toshiaki, et al.
Publicado: (1999)

Interferon-γ acts directly on CD8(+) T cells to increase their abundance during virus infection
por: Whitmire, Jason K., et al.
Publicado: (2005)

Enhanced cGAS-STING–dependent interferon signaling associated with mutations in ATAD3A
por: Lepelley, Alice, et al.
Publicado: (2021)

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
por: Peggs, Karl S., et al.
Publicado: (2009)

Enhanced TCR-induced Apoptosis in Interferon Regulatory Factor 4–deficient CD4(+) Th Cells
por: Lohoff, Michael, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_8uo2van290616i43kvene6osaa